Drug intelligence / Profile preview

fanft

Development stage
Unknown
Modality
Small Molecules
Administration
Intragastric Administration, Intraperitoneal Administration
01

Overview

FANFT is a **synthetic nitrofuran derivative** with the chemical name **N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide** and molecular formula C8H5N3O4S[7]. It is a **dark yellow powder or gold solid** and is **insoluble in water**[2]. FANFT is primarily used as a research chemical and is recognized as a **potent urinary bladder carcinogen** in animal studies[8][2][6]. Its carcinogenic and mutagenic effects serve as a model for studying chemical carcinogenesis, particularly related to nitrofuran derivatives, affecting organs such as the bladder, forestomach, mammary gland, and kidney[2][8]. Its mechanism of toxicity involves metabolic activation likely associated with the nitro group on the furan ring. FANFT has demonstrated mutagenic and reproductive toxicity in experimental systems[2]. It is not intended for human or veterinary use[2].

Other names
N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamideN-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide2-Formylamino-4-(5-nitro-2-furyl)thiazole

Beyond the preview

Go deeper on fanft.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fanft.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call